Lee et al, 1 comprising authors from a number of institutions, published a retrospective observational study conducted on 147 consecutive patients who underwent endoscopic enucleation of the prostate ...

UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.

Maha Hussain discusses overall survival data from BRCAAway, a phase 2 trial comparing upfront combination abiraterone plus olaparib against monotherapy with sequencing in HRR-mutated metastatic ...

Creating real-time access to evidence-based findings from anywhere in the world, coverage written by clinicians for urology, medical oncology, and radiation oncology conferences.

EAU 2026 results from the PRISMA-PET randomized trial, 8F-PSMA-1007-PET/CT versus 18NaF-PET/CT in prostate cancer, PRISMA-PET.

(UroToday.com) The 2026 PSMA & Beyond conference featured a clinical trial updates session and presentation by Dr. Nick James discussing the STAMPEDE2 PSMA-Lu comparison. An overview of prostate ...

(UroToday.com) The 2026 ASCO GU Annual Symposium was host to a prostate cancer poster session. Jasmine Lee presented a study of treatment interruption guided by on-treatment PSMA PET/CT imaging in ...

The 2026 PSMA & Beyond conference featured a developing novel radioligands session and presentation by Dr. Wolfgang Fendler discussing the pro stance for the future of FAP. Fibroblast Activation ...

The 2026 PSMA & Beyond conference featured a challenges of radioligand therapy session and a presentation by Dr. Daniel Childs discussing long term marrow toxicity rates and risk factors. 177 ...

Dr. Morris then discussed the PCWG4 Rule of 5 for defining radiographic progression free survival in the post-flare period. If there are <=5 new metastases, a confirmatory scan is performed, and if ...

The 2026 PSMA & Beyond conference featured a developing novel radioligands session and presentation by Dr. Lena Unterrainer discussing the con stance for the future of FAP. The primary challenge with ...

The 2026 PSMA & Beyond conference featured a clinical development session and presentation by Stephanie Lira discussing scaling operations in theranostics clinical research. There has been tremendous ...